实用肿瘤学杂志 ›› 2018, Vol. 32 ›› Issue (1): 82-86.doi: 10.11904/j.issn.1002-3070.2018.01.016

• 综述 • 上一篇    下一篇

ICAM-1在肿瘤中的研究进展

庄敏敏 综述, 张云艳 审校   

  1. 哈尔滨医科大学附属肿瘤医院(哈尔滨 150081)
  • 收稿日期:2017-07-30 出版日期:2018-02-20 发布日期:2018-03-07
  • 通讯作者: 张云艳,E-mail:zhangyunyan-1972@163.com
  • 作者简介:庄敏敏,女,(1990-),硕士研究生,从事宫颈癌放疗增敏的研究。

Research progress of intercellular adhesion molecule-1 in tumor

ZHUANG Minmin, ZHANG Yunyan   

  1. Harbin Medical University Cancer Hospital,Harbin 150081,China
  • Received:2017-07-30 Online:2018-02-20 Published:2018-03-07

摘要: 细胞间黏附分子(Intercellular adhesion molecule-1,ICAM-1)又称CD54,是免疫球蛋白超家族的一种跨膜糖蛋白,参与肿瘤细胞免疫调节、血管生成、侵袭和远处转移。国内外诸多研究证明ICAM-1在多种恶性肿瘤中异常高表达,促进了肿瘤的发生、发展并影响其预后,同时对预测个别肿瘤放化疗敏感性有一定的作用。因此ICAM-1可能为恶性肿瘤的诊断和治疗提供参考依据。本文就近年来ICAM-1在恶性肿瘤中的研究做一综述。

关键词: ICAM-1, 肿瘤, 进展, 预后

Abstract: Intercellular adhesion molecule(ICAM-1),also known as CD54,is a transmembrane glycoprotein of the immunoglobulin superfamily and involved in tumor cell immune regulation,angiogenesis,invasion and distant metastasis.Many studies from domestic and abroad have proved that ICAM-1 is highly expressed in a variety of malignant tumors,which promotes the occurrence,development and prognosis of tumor.ICAM-1 also plays an important role in predicting the chemosensitivity of individual tumors.Therefore,ICAM-1 may provide a reference for the diagnosis and treatment of malignant tumors.This article summarizes effects of ICAM-1 on malignant tumors in recent years.

Key words: ICAM-1, Tumor, Progress, Prognosis

中图分类号: